Literature DB >> 3741070

Total hip replacement with Müller prosthesis and ICLH double cup. 2- to 6-year results of a prospective comparative study.

A Reigstad, M Brandt, K R Hetland.   

Abstract

A prospective comparative study was made of patients in the age-group 60-79 years with osteoarthritis of the hip treated with the Müller total hip prosthesis (n = 155) and the ICLH double-cup prosthesis (n = 149). The patients were comparable with regard to sex, mean age, and body weight, and the preoperative radiographic appearance of the hips was th same in the two groups. The mean operating time was significantly shorter in the Müller group, whereas the operative blood loss and the operative complications were statistically equal. No deep infections occurred in either group. The incidence of systemic complications was low and no difference between the two groups was seen. The patients are followed up for an average of 48.5 months (range: 27-75 months). Dramatic improvement in hip function was seen postoperatively in both prosthetic groups. The Müller group had more favorable ratings than the ICLH group for pain, walking ability, hip motion, and total hip score at all follow-ups, from 3 weeks to 5 years after the operation. However, the differences were rather small and did not reach a significant level at any registration. The acetabular radiolucent zones and heterotopic bone formation were statistically equal in the two groups. No revision operations have been done in the Müller group. Two Müller prostheses have shown radiographic signs of mechanical loosening. Thirteen ICLH prostheses (8.7%)--all in female patients--have been reoperated (P less than 0.001), 12 owing to mechanical loosening and one because of pain and stiffness.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1986        PMID: 3741070     DOI: 10.1007/bf00433937

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0344-8444


  29 in total

1.  Rearthroplasty after conventional total hip prosthesis and double-cup prosthesis. A comparative study.

Authors:  A Reigstad; K R Hetland
Journal:  Arch Orthop Trauma Surg       Date:  1984

2.  [Follow up study of 997 total hip endoprostheses with special reference to late results 9-11 years after operation].

Authors:  H Gierse; W Schramm
Journal:  Z Orthop Ihre Grenzgeb       Date:  1984 Nov-Dec

3.  Surface replacement of the hip joint.

Authors:  S Tanaka
Journal:  Clin Orthop Relat Res       Date:  1978 Jul-Aug       Impact factor: 4.176

4.  Socket and cup surface replacement of the hip.

Authors:  A Nishio; M Eguchi; N Kaibara
Journal:  Clin Orthop Relat Res       Date:  1978 Jul-Aug       Impact factor: 4.176

5.  [Early complication of the hip joint surface replacement according to Wagner (author's transl)].

Authors:  M Spranger; H Eder
Journal:  Arch Orthop Trauma Surg       Date:  1980

6.  Wagner surface replacement arthroplasty of the hip. Analysis of fourteen failures in forty-one hips.

Authors:  W C Head
Journal:  J Bone Joint Surg Am       Date:  1981-03       Impact factor: 5.284

7.  Ten-year follow-up of Müller hip replacements.

Authors:  O Reikerås
Journal:  Acta Orthop Scand       Date:  1982-12

8.  Cemented double cup arthroplasty of the hip: a 5 year experience with the ICLH prosthesis.

Authors:  M A Freeman; H U Cameron; G C Brown
Journal:  Clin Orthop Relat Res       Date:  1978 Jul-Aug       Impact factor: 4.176

9.  Early results and complications of surface replacement of the hip.

Authors:  M N Jolley; E A Salvati; G C Brown
Journal:  J Bone Joint Surg Am       Date:  1982-03       Impact factor: 5.284

10.  Rearthroplasty of the hip joint.

Authors:  R Wallensten; E Olsson
Journal:  Acta Orthop Scand       Date:  1982-04
View more
  3 in total

Review 1.  Biological Functions of Plasmalogens.

Authors:  Md Shamim Hossain; Shiro Mawatari; Takehiko Fujino
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 2.  Depression-an underrecognized target for prevention of dementia in Alzheimer's disease.

Authors:  Forugh S Dafsari; Frank Jessen
Journal:  Transl Psychiatry       Date:  2020-05-20       Impact factor: 6.222

3.  Ergothioneine, a metabolite of the gut bacterium Lactobacillus reuteri, protects against stress-induced sleep disturbances.

Authors:  Yoshiki Matsuda; Nobuyuki Ozawa; Takiko Shinozaki; Ken-Ichi Wakabayashi; Kosuke Suzuki; Yusuke Kawano; Iwao Ohtsu; Yoshitaka Tatebayashi
Journal:  Transl Psychiatry       Date:  2020-05-28       Impact factor: 6.222

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.